Related Experiment Video
Updated: Aug 18, 2026

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
Increased monocyte tissue factor expression in coronary disease
E W Leatham1, P M Bath, J A Tooze
1Department of Cardiological Sciences, St George's Hospital Medical School, London.
Insights
Monocyte tissue factor expression is elevated in patients with acute coronary syndromes and chronic stable angina, contributing to hypercoagulability. This finding highlights tissue factor
Area of Science:
- Cardiovascular Medicine
- Hematology
- Immunology
Background:
- Unstable angina and myocardial infarction are linked to increased mononuclear cell procoagulant activity.
- Monocyte procoagulant activity is primarily mediated by tissue factor (TF) expression.
- TF initiates the coagulation cascade, suggesting a potential role in ischemic heart disease syndromes.
Purpose of the Study:
- To determine if monocyte expression of tissue factor (TF) is elevated in patients with acute coronary syndromes (ACS) and chronic stable angina (CSA).
- To investigate the association between TF expression on monocytes and ischemic heart disease.
Main Methods:
- A cross-sectional study design was employed.
- Monocyte TF expression was quantified using flow cytometry with a polyclonal rabbit anti-human TF antibody.
- Participants included patients with acute myocardial infarction (AMI), unstable angina (UA), CSA, and healthy controls.
Main Results:
- Significantly higher proportions of monocytes expressing TF were observed in patients with CSA (38%), UA (64%), and AMI (53%) compared to controls (0%).
- Monocyte TF expression levels were statistically significant across the patient groups (2P = 0.006).
- Lipopolysaccharide stimulation resulted in similar monocyte TF expression across all subjects, indicating disease-specific upregulation.
Conclusions:
- Elevated tissue factor expression on circulating monocytes may contribute to the hypercoagulable state associated with AMI, UA, and CSA.
- Monocyte TF represents a potential therapeutic target for managing thrombotic complications in ischemic heart disease.
Objective:
To investigate whether monocyte expression of tissue factor is increased in patients with acute coronary syndromes and chronic stable angina.
Design:
Cross sectional study of monocyte tissue factor expression in patients with ischaemic heart disease and control subjects.
Background:
Unstable angina and myocardial infarction are associated with enhanced mononuclear cell procoagulant activity. Procoagulant activity of blood monocytes is principally mediated by tissue factor expression. Tissue factor initiates the coagulation cascade and monocyte tissue factor expression may therefore be increased in these syndromes.
Methods:
Monocyte tissue factor expression was measured cytometrically in whole blood flow using a polyclonal rabbit antihuman tissue factor antibody.
Patients:
30 patients with acute myocardial infarction, 17 with unstable angina, 13 with chronic stable angina, and 11 normal control subjects.
Results:
Increased proportions of monocytes expressing tissue factor (> 2.5%) were found in none of 11 (0%) normal subjects, five 13 (38%) patients with stable angina, 11 of 17 (64%) patients with unstable angina, and 16 of 30 (53%) patients with myocardial infarction (2P = 0.006). Blood from all subjects showed similar monocyte tissue factor expression similar monocyte tissue factor expression (46.1 (15.1)%) after lipopolysaccharide stimulation.
Conclusion:
Hypercoagulability associated with acute myocardial infarction, unstable angina, and chronic stable angina may be induced by tissue factor expressed on circulating monocytes.
More Related Videos
Related Concept Videos
Inflammation
Myocarditis I: Introduction
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Chronic Inflammation: Introduction

